Publication | Closed Access

Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study

RheumatologyRadiological Disease ActivitySystemic SclerodermaMedicineImmunologyClinical TrialsNeurological ProgressMultiple SclerosisNatalizumab SafetyNeuroimmunology